Dorothee E. Schliephake

488 total citations
9 papers, 323 citations indexed

About

Dorothee E. Schliephake is a scholar working on Surgery, Internal Medicine and Dermatology. According to data from OpenAlex, Dorothee E. Schliephake has authored 9 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Internal Medicine and 3 papers in Dermatology. Recurrent topics in Dorothee E. Schliephake's work include Diagnosis and Treatment of Venous Diseases (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Dermatologic Treatments and Research (3 papers). Dorothee E. Schliephake is often cited by papers focused on Diagnosis and Treatment of Venous Diseases (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Dermatologic Treatments and Research (3 papers). Dorothee E. Schliephake collaborates with scholars based in Germany, United States and Australia. Dorothee E. Schliephake's co-authors include Joachim Otto, Eberhard Rabe, Felizitas Pannier, Anneliese Schimpl, F. X. Breu, François‐André Allaert, Antoní Torres, J J Guex, Christopher Wynne and Benjamin Lang and has published in prestigious journals such as European Journal of Immunology, Respiratory Medicine and European Journal of Vascular and Endovascular Surgery.

In The Last Decade

Dorothee E. Schliephake

9 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dorothee E. Schliephake Germany 7 192 152 103 90 31 9 323
Giovanna Cozzi Italy 12 111 0.6× 42 0.3× 13 0.1× 72 0.8× 17 0.5× 24 492
Hamish Hamilton United Kingdom 12 152 0.8× 6 0.0× 6 0.1× 111 1.2× 34 1.1× 19 366
Phillip Fleshner United States 9 225 1.2× 19 0.1× 4 0.0× 18 0.2× 81 2.6× 43 391
Hilary Whitworth United States 9 118 0.6× 68 0.4× 6 0.1× 4 0.0× 12 0.4× 20 308
Russell-Jones United Kingdom 8 19 0.1× 19 0.1× 101 1.0× 33 0.4× 53 1.7× 11 245
Aruna Pawar India 8 50 0.3× 54 0.4× 6 0.1× 65 0.7× 37 1.2× 16 312
Sarina Levy‐Mendelovich Israel 10 31 0.2× 50 0.3× 2 0.0× 32 0.4× 12 0.4× 48 340
P Flory France 8 77 0.4× 6 0.0× 18 0.2× 51 0.6× 26 0.8× 8 300
Robert Eilers United States 7 56 0.3× 10 0.1× 92 0.9× 6 0.1× 61 2.0× 9 233
B. J. Hunt United Kingdom 5 67 0.3× 11 0.1× 8 0.1× 54 0.6× 7 0.2× 10 250

Countries citing papers authored by Dorothee E. Schliephake

Since Specialization
Citations

This map shows the geographic impact of Dorothee E. Schliephake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothee E. Schliephake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothee E. Schliephake more than expected).

Fields of papers citing papers by Dorothee E. Schliephake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorothee E. Schliephake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothee E. Schliephake. The network helps show where Dorothee E. Schliephake may publish in the future.

Co-authorship network of co-authors of Dorothee E. Schliephake

This figure shows the co-authorship network connecting the top 25 collaborators of Dorothee E. Schliephake. A scholar is included among the top collaborators of Dorothee E. Schliephake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorothee E. Schliephake. Dorothee E. Schliephake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kim, Edward S., et al.. (2021). Phase 3 Trial of BI 695502 Plus Chemotherapy Versus Bevacizumab Reference Product Plus Chemotherapy in Patients With Advanced Nonsquamous NSCLC. JTO Clinical and Research Reports. 3(1). 100248–100248. 5 indexed citations
2.
Wynne, Christopher, et al.. (2017). A randomized, single-blind, Phase I trial (INVICTAN-1) assessing the bioequivalence and safety of BI 695502, a bevacizumab biosimilar candidate, in healthy subjects. Expert Opinion on Investigational Drugs. 26(8). 889–896. 23 indexed citations
3.
Welte, Tobias, R. Phillip Dellinger, Henning Ebelt, et al.. (2015). Concept for a study design in patients with severe community-acquired pneumonia: A randomised controlled trial with a novel IGM-enriched immunoglobulin preparation – The CIGMA study. Respiratory Medicine. 109(6). 758–767. 27 indexed citations
5.
Guex, J J, et al.. (2010). The French Polidocanol Study on Long-Term Side Effects. Dermatologic Surgery. 36(Sup 2). 993–1003. 16 indexed citations
6.
Rabe, Eberhard, Dorothee E. Schliephake, Joachim Otto, F. X. Breu, & Felizitas Pannier. (2010). Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study). Phlebology The Journal of Venous Disease. 25(3). 124–131. 47 indexed citations
7.
Schliephake, Dorothee E., et al.. (2010). Effektivität der Sklerosierungstherapie in Abhängigkeit vom Alter der Patienten. Phlebologie. 39(4). 202–207. 2 indexed citations
8.
Rabe, Eberhard, Joachim Otto, Dorothee E. Schliephake, & Felizitas Pannier. (2007). Efficacy and Safety of Great Saphenous Vein Sclerotherapy Using Standardised Polidocanol Foam (ESAF): A Randomised Controlled Multicentre Clinical Trial. European Journal of Vascular and Endovascular Surgery. 35(2). 238–245. 116 indexed citations
9.
Schliephake, Dorothee E. & Anneliese Schimpl. (1996). Blimp‐1 overcomes the block in IgM secretion in lipopolysaccharide / anti‐μ F(ab′)2‐co‐stimulated B lymphocytes. European Journal of Immunology. 26(1). 268–271. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026